US FDA Suspends All Domestic GMP Surveillance Inspections
Agency responds to COVID-19 pandemic's US arrival by suspending domestic surveillance inspections and non-critical for-cause and preapproval inspections.
You may also be interested in...
Productivity may suffer under coronavirus-mandated telework despite workforce diligence, experts say.
Sponsors have been asked to switch to teleconferences with FDA staff as the agency prepares for more of its employees to work from home.
The US FDA has added hydroxychloroquine sulfate to the list of drugs outsourcing facilities can compound as pharmacy group calls for more such approvals with COVID-19 driving demand for additional prescription and over-the-counter drugs.